1
0
0
News
Netzwerk-Profile
Joachim Weis: search on Z-Libraryarticle.sk
article.sk
Dagmar Beier, Beate Schriefer, Konstantin Brawanski, Peter Hau, Joachim Weis, Jörg B. Schulz, Christoph P. Beier. Journal: Journal of Neuro-Oncology. Year ... Dagmar Beier, Beate Schriefer, Konstantin Brawanski, Peter Hau, Joachim Weis, Jörg B. Schulz, Christoph P. Beier. Journal: Journal of Neuro-Oncology. Year ...
Dokumente zum Namen
Efficacy of clinically relevant temozolomide dosing schemes in...
fdocuments.net
LABORATORY INVESTIGATION Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines Dagmar Beier • Beate Schriefer •...
Veröffentlichungen allgemein
Effects of Gamdutang Aqua-acupuncture Solution on Tumor Cell ...ResearchGate
www.researchgate.net
Beate Schriefer · Konstantin Brawanski; [...] Christoph Beier. The effectiveness of temozolomide (TMZ) dosing schemes and the "rechallenge" of ... Beate Schriefer · Konstantin Brawanski; [...] Christoph Beier. The effectiveness of temozolomide (TMZ) dosing schemes and the "rechallenge" of ...
Efficacy of clinically relevant temozolomide dosing schemes in...
link.springer.com
Dagmar Beier • Beate Schriefer • Konstantin Brawanski •. Peter Hau • Joachim Weis • Jörg B. Schulz •. Christoph P. Beier. Received: 28 June ...
Sonstiges
A quantitative characterization of the heterogeneous ...bioRxiv
www.biorxiv.org
von P Dixit · — Beier, Dagmar, Beate Schriefer, Konstantin Brawanski, Peter Hau, Joachim Weis, Jörg B. Schulz, and Christoph P. Beier 'Efficacy of Seiten
Clinically relevant doses of chemotherapy agents reversibly ...Semantic Scholar
www.semanticscholar.org
BeierBeate Schriefer +4 authors. C. Beier. Medicine. Journal of Neuro-Oncology TLDR. The 7 days on/7 days off scheme consistently showed the best ... BeierBeate Schriefer +4 authors. C. Beier. Medicine. Journal of Neuro-Oncology TLDR. The 7 days on/7 days off scheme consistently showed the best ...
Efficacy of clinically relevant temozolomide dosing ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von D Beier · · Zitiert von: 49 — Epub Apr 29. Authors. Dagmar Beier , Beate Schriefer, Konstantin Brawanski, Peter Hau, Joachim Weis, Jörg B Schulz, Christoph P Beier. Affiliation von D Beier · · Zitiert von: 49 — Epub Apr 29. Authors. Dagmar Beier , Beate Schriefer, Konstantin Brawanski, Peter Hau, Joachim Weis, Jörg B Schulz, Christoph P Beier. Affiliation
Efficacy of clinically relevant temozolomide dosing schemes in ...Academia.edu
www.academia.edu
... Beate Schriefer • Konstantin Brawanski Peter Hau • Joachim Weis • Jörg B. Schulz • Christoph P. Beier • Received: 28 June Accepted: 16 April Beate Schriefer • Konstantin Brawanski Peter Hau • Joachim Weis • Jörg B. Schulz • Christoph P. Beier • Received: 28 June Accepted: 16 April
Efficacy of clinically relevant temozolomide dosing schemes in ...Syddansk Universitet
portal.findresearcher.sdu.dk
Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines. Dagmar Beier, Beate Schriefer, Konstantin Brawanski ... Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines. Dagmar Beier, Beate Schriefer, Konstantin Brawanski ...
[PDF] Considering the Experimental Use of Temozolomide in ...Semantic Scholar
www.semanticscholar.org
Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines · D. BeierBeate Schriefer +4 authors. C. Beier. Medicine. Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines · D. BeierBeate Schriefer +4 authors. C. Beier. Medicine.
Verwandte Suchanfragen zu Beate Schriefer
| Konstantin Brawanski Joachim Weis |
Person "Schriefer" (2) Vorname "Beate" (25845) Name "Schriefer" (206) |
sortiert nach Relevanz / Datum